Research
Schering-Plough Research Institute, Gene Therapy of Primary and Metastatic Malignant\r\nTumors of the Liver Using SCH 58500 (rAd/p53) Via Hepatic Artery Infusion: A\r\nPhase I Study
\r\nA Two-Stage Phase II Safety and Efficacy\r\n Study of Intradose (Cisplatin/Epinephrine) Injectable Gel Administered to Patients\r\n with Unresectable Intrahepatic Colorectal Metastases
\r\nA Two-Stage Phase II Safety and Efficacy\r\n Study of IntraDose (Displatin/Epinephrine) Injectable Gel Administered to Patients\r\n with Unresectable Primary Hepatocellular Carcinoma
\r\nThe Long Island Breast Cancer Study Project
\r\nCALGB protocol 9481: Phase III Study of Hepatic Artery FUDR, Leucovorin (LV)\r\n and Dexamethasone versus systemic 5-Fu and LV as treatment for hepatic metastases\r\n from colorectal cancer
\r\nECOG Protocol 3292: Biologic correlates to response and survival in colon\r\n cancer
\r\nNIH study: Genetics of Breast Cancer Among Women of Jewish Ancestry
\r\nCALGB protocol 9670: Barriers to Participation of Older Women with Breast\r\n Cancer in Clinical Trials: A Pilot Study
\r\nIntergroup protocol 9288, SWOG 8990: Combined modality treatment of hepatic\r\n metastases from colorectal cancer
\r\nIntergroup protocol ECOG 1292, SWOG 9250, CALGB 9395: Phase III Intergroup\r\n prospectively randomiized trial of perioperative 5FU after curative resection\r\n followed by 5 FU/levamisole for patients with colon cancer
\r\n